Ana
Alfonso Piérola
Investigadora Consultora
![Foto de Ana](/img/nophoto.png)
![Foto de Clínica Universitaria de Navarra](/img/noimage_org.png)
Clínica Universitaria de Navarra
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (11)
2024
-
Myelodysplastic neoplasms
Medicina Clinica, Vol. 162, Núm. 2, pp. 77-82
-
Single-cell transcriptional profile of CD34+ hematopoietic progenitor cells from del(5q) myelodysplastic syndromes and impact of lenalidomide
Nature Communications, Vol. 15, Núm. 1
2023
2021
-
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
Leukemia, Vol. 35, Núm. 12, pp. 3542-3550
2019
-
Improvement of appropriate pharmacological prophylaxis in hospitalised cancer patients with a multiscreen e-alert system: a single-centre experience
Clinical and Translational Oncology, Vol. 21, Núm. 6, pp. 805-809
2018
2016
-
Identification of new markers of recurrence in patients with unprovoked deep vein thrombosis by gene expression profiling: the retro study
European Journal of Haematology, Vol. 97, Núm. 2, pp. 128-136
2015
-
Factors influencing the use of thromboprophylaxis in cancer outpatients in clinical practice: A prospective study
Thrombosis Research, Vol. 136, Núm. 6, pp. 1145-1148
-
Short-term heparin re-exposure during heart transplantation in patients with ventricular assist devices and acute heparin-induced thrombocytopenia
Revista Espanola de Cardiologia
2013
-
High incidence of venous thromboembolism despite electronic alerts for thromboprophylaxis in hospitalised cancer patients
Thrombosis and Haemostasis, Vol. 110, Núm. 1, pp. 184-190
-
Screening for occult malignancy with FDG-PET/CT in patients with unprovoked venous thromboembolism
International Journal of Cancer, Vol. 133, Núm. 9, pp. 2157-2164